subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "522"
part_subject: "IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "522.1452"
section_subject: "Nalorphine."
cfr_reference: "21 CFR 522.1452"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Each milliliter of solution contains 5 milligrams of nalorphine hydrochloride.
(b)Sponsor. See No. 050604 in § 510.600(c) of this chapter.
(c)Conditions of use in dogs—(1) Amount. One milligram per 5 pounds; intravenously, intramuscularly, or subcutaneously.
(2)Indications for use. Respiratory and circulatory depression in dogs resulting from overdosage of, or unusual sensitivity to, morphine and certain other narcotics. Not for depression due to any other cause.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.